Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

An important role of lymphatic vessel activation in limiting acute inflammation

Identifieur interne : 005100 ( Main/Exploration ); précédent : 005099; suivant : 005101

An important role of lymphatic vessel activation in limiting acute inflammation

Auteurs : Reto Huggenberger ; Shoib S. Siddiqui ; Daniela Brander ; Stefan Ullmann ; Kathrin Zimmermann ; Maria Antsiferova [Suisse] ; Sabine Werner [Suisse] ; Kari Alitalo [Finlande] ; Michael Detmar

Source :

RBID : PMC:3099581

Abstract

In contrast to the established role of blood vessel remodeling in inflammation, the biologic function of the lymphatic vasculature in acute inflammation has remained less explored. We studied 2 established models of acute cutaneous inflammation, namely, oxazolone-induced delayed-type hypersensitivity reactions and ultraviolet B irradiation, in keratin 14-vascular endothelial growth factor (VEGF)-C and keratin 14-VEGF-D transgenic mice. These mice have an expanded network of cutaneous lymphatic vessels. Transgenic delivery of the lymphangiogenic factors VEGF-C and the VEGFR-3 specific ligand mouse VEGF-D significantly limited acute skin inflammation in both experimental models, with a strong reduction of dermal edema. Expression of VEGFR-3 by lymphatic endothelium was strongly down-regulated at the mRNA and protein level in acutely inflamed skin, and no VEGFR-3 expression was detectable on inflamed blood vessels and dermal macrophages. There was no major change of the inflammatory cell infiltrate or the composition of the inflammatory cytokine milieu in the inflamed skin of VEGF-C or VEGF-D transgenic mice. However, the increased network of lymphatic vessels in these mice significantly enhanced lymphatic drainage from the ear skin. These results provide evidence that specific lymphatic vessel activation limits acute skin inflammation via promotion of lymph flow from the skin and reduction of edema formation.


Url:
DOI: 10.1182/blood-2010-10-316356
PubMed: 21364190
PubMed Central: 3099581


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">An important role of lymphatic vessel activation in limiting acute inflammation</title>
<author>
<name sortKey="Huggenberger, Reto" sort="Huggenberger, Reto" uniqKey="Huggenberger R" first="Reto" last="Huggenberger">Reto Huggenberger</name>
<affiliation>
<nlm:aff wicri:cut=" and" id="aff1">Institute of Pharmaceutical Sciences</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Siddiqui, Shoib S" sort="Siddiqui, Shoib S" uniqKey="Siddiqui S" first="Shoib S." last="Siddiqui">Shoib S. Siddiqui</name>
<affiliation>
<nlm:aff wicri:cut=" and" id="aff1">Institute of Pharmaceutical Sciences</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Brander, Daniela" sort="Brander, Daniela" uniqKey="Brander D" first="Daniela" last="Brander">Daniela Brander</name>
<affiliation>
<nlm:aff wicri:cut=" and" id="aff1">Institute of Pharmaceutical Sciences</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Ullmann, Stefan" sort="Ullmann, Stefan" uniqKey="Ullmann S" first="Stefan" last="Ullmann">Stefan Ullmann</name>
<affiliation>
<nlm:aff wicri:cut=" and" id="aff1">Institute of Pharmaceutical Sciences</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Zimmermann, Kathrin" sort="Zimmermann, Kathrin" uniqKey="Zimmermann K" first="Kathrin" last="Zimmermann">Kathrin Zimmermann</name>
<affiliation>
<nlm:aff wicri:cut=" and" id="aff1">Institute of Pharmaceutical Sciences</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Antsiferova, Maria" sort="Antsiferova, Maria" uniqKey="Antsiferova M" first="Maria" last="Antsiferova">Maria Antsiferova</name>
<affiliation wicri:level="1">
<nlm:aff wicri:cut="; and" id="aff2">Institute of Cell Biology, Swiss Federal Institute of Technology, ETH Zurich, Zurich, Switzerland</nlm:aff>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Institute of Cell Biology, Swiss Federal Institute of Technology, ETH Zurich, Zurich</wicri:regionArea>
<wicri:noRegion>Zurich</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Werner, Sabine" sort="Werner, Sabine" uniqKey="Werner S" first="Sabine" last="Werner">Sabine Werner</name>
<affiliation wicri:level="1">
<nlm:aff wicri:cut="; and" id="aff2">Institute of Cell Biology, Swiss Federal Institute of Technology, ETH Zurich, Zurich, Switzerland</nlm:aff>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Institute of Cell Biology, Swiss Federal Institute of Technology, ETH Zurich, Zurich</wicri:regionArea>
<wicri:noRegion>Zurich</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Alitalo, Kari" sort="Alitalo, Kari" uniqKey="Alitalo K" first="Kari" last="Alitalo">Kari Alitalo</name>
<affiliation wicri:level="4">
<nlm:aff id="aff3">Molecular/Cancer Biology Laboratory, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland</nlm:aff>
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>Molecular/Cancer Biology Laboratory, Biomedicum Helsinki, University of Helsinki, Helsinki</wicri:regionArea>
<orgName type="university">Université d'Helsinki</orgName>
<placeName>
<settlement type="city">Helsinki</settlement>
<region type="région" nuts="2">Uusimaa</region>
</placeName>
<placeName>
<settlement type="city">Helsinki</settlement>
<region type="région" nuts="2">Uusimaa</region>
</placeName>
<orgName type="university">Université d'Helsinki</orgName>
</affiliation>
</author>
<author>
<name sortKey="Detmar, Michael" sort="Detmar, Michael" uniqKey="Detmar M" first="Michael" last="Detmar">Michael Detmar</name>
<affiliation>
<nlm:aff wicri:cut=" and" id="aff1">Institute of Pharmaceutical Sciences</nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">21364190</idno>
<idno type="pmc">3099581</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3099581</idno>
<idno type="RBID">PMC:3099581</idno>
<idno type="doi">10.1182/blood-2010-10-316356</idno>
<date when="2011">2011</date>
<idno type="wicri:Area/Pmc/Corpus">002C66</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">002C66</idno>
<idno type="wicri:Area/Pmc/Curation">002C65</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">002C65</idno>
<idno type="wicri:Area/Pmc/Checkpoint">003105</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">003105</idno>
<idno type="wicri:Area/Ncbi/Merge">004166</idno>
<idno type="wicri:Area/Ncbi/Curation">004166</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004166</idno>
<idno type="wicri:doubleKey">0006-4971:2011:Huggenberger R:an:important:role</idno>
<idno type="wicri:Area/Main/Merge">005139</idno>
<idno type="wicri:Area/Main/Curation">005100</idno>
<idno type="wicri:Area/Main/Exploration">005100</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">An important role of lymphatic vessel activation in limiting acute inflammation</title>
<author>
<name sortKey="Huggenberger, Reto" sort="Huggenberger, Reto" uniqKey="Huggenberger R" first="Reto" last="Huggenberger">Reto Huggenberger</name>
<affiliation>
<nlm:aff wicri:cut=" and" id="aff1">Institute of Pharmaceutical Sciences</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Siddiqui, Shoib S" sort="Siddiqui, Shoib S" uniqKey="Siddiqui S" first="Shoib S." last="Siddiqui">Shoib S. Siddiqui</name>
<affiliation>
<nlm:aff wicri:cut=" and" id="aff1">Institute of Pharmaceutical Sciences</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Brander, Daniela" sort="Brander, Daniela" uniqKey="Brander D" first="Daniela" last="Brander">Daniela Brander</name>
<affiliation>
<nlm:aff wicri:cut=" and" id="aff1">Institute of Pharmaceutical Sciences</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Ullmann, Stefan" sort="Ullmann, Stefan" uniqKey="Ullmann S" first="Stefan" last="Ullmann">Stefan Ullmann</name>
<affiliation>
<nlm:aff wicri:cut=" and" id="aff1">Institute of Pharmaceutical Sciences</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Zimmermann, Kathrin" sort="Zimmermann, Kathrin" uniqKey="Zimmermann K" first="Kathrin" last="Zimmermann">Kathrin Zimmermann</name>
<affiliation>
<nlm:aff wicri:cut=" and" id="aff1">Institute of Pharmaceutical Sciences</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Antsiferova, Maria" sort="Antsiferova, Maria" uniqKey="Antsiferova M" first="Maria" last="Antsiferova">Maria Antsiferova</name>
<affiliation wicri:level="1">
<nlm:aff wicri:cut="; and" id="aff2">Institute of Cell Biology, Swiss Federal Institute of Technology, ETH Zurich, Zurich, Switzerland</nlm:aff>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Institute of Cell Biology, Swiss Federal Institute of Technology, ETH Zurich, Zurich</wicri:regionArea>
<wicri:noRegion>Zurich</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Werner, Sabine" sort="Werner, Sabine" uniqKey="Werner S" first="Sabine" last="Werner">Sabine Werner</name>
<affiliation wicri:level="1">
<nlm:aff wicri:cut="; and" id="aff2">Institute of Cell Biology, Swiss Federal Institute of Technology, ETH Zurich, Zurich, Switzerland</nlm:aff>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Institute of Cell Biology, Swiss Federal Institute of Technology, ETH Zurich, Zurich</wicri:regionArea>
<wicri:noRegion>Zurich</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Alitalo, Kari" sort="Alitalo, Kari" uniqKey="Alitalo K" first="Kari" last="Alitalo">Kari Alitalo</name>
<affiliation wicri:level="4">
<nlm:aff id="aff3">Molecular/Cancer Biology Laboratory, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland</nlm:aff>
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>Molecular/Cancer Biology Laboratory, Biomedicum Helsinki, University of Helsinki, Helsinki</wicri:regionArea>
<orgName type="university">Université d'Helsinki</orgName>
<placeName>
<settlement type="city">Helsinki</settlement>
<region type="région" nuts="2">Uusimaa</region>
</placeName>
<placeName>
<settlement type="city">Helsinki</settlement>
<region type="région" nuts="2">Uusimaa</region>
</placeName>
<orgName type="university">Université d'Helsinki</orgName>
</affiliation>
</author>
<author>
<name sortKey="Detmar, Michael" sort="Detmar, Michael" uniqKey="Detmar M" first="Michael" last="Detmar">Michael Detmar</name>
<affiliation>
<nlm:aff wicri:cut=" and" id="aff1">Institute of Pharmaceutical Sciences</nlm:aff>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Blood</title>
<idno type="ISSN">0006-4971</idno>
<idno type="eISSN">1528-0020</idno>
<imprint>
<date when="2011">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>In contrast to the established role of blood vessel remodeling in inflammation, the biologic function of the lymphatic vasculature in acute inflammation has remained less explored. We studied 2 established models of acute cutaneous inflammation, namely, oxazolone-induced delayed-type hypersensitivity reactions and ultraviolet B irradiation, in keratin 14-vascular endothelial growth factor (VEGF)-C and keratin 14-VEGF-D transgenic mice. These mice have an expanded network of cutaneous lymphatic vessels. Transgenic delivery of the lymphangiogenic factors VEGF-C and the VEGFR-3 specific ligand mouse VEGF-D significantly limited acute skin inflammation in both experimental models, with a strong reduction of dermal edema. Expression of VEGFR-3 by lymphatic endothelium was strongly down-regulated at the mRNA and protein level in acutely inflamed skin, and no VEGFR-3 expression was detectable on inflamed blood vessels and dermal macrophages. There was no major change of the inflammatory cell infiltrate or the composition of the inflammatory cytokine milieu in the inflamed skin of VEGF-C or VEGF-D transgenic mice. However, the increased network of lymphatic vessels in these mice significantly enhanced lymphatic drainage from the ear skin. These results provide evidence that specific lymphatic vessel activation limits acute skin inflammation via promotion of lymph flow from the skin and reduction of edema formation.</p>
</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Finlande</li>
<li>Suisse</li>
</country>
<region>
<li>Uusimaa</li>
</region>
<settlement>
<li>Helsinki</li>
</settlement>
<orgName>
<li>Université d'Helsinki</li>
</orgName>
</list>
<tree>
<noCountry>
<name sortKey="Brander, Daniela" sort="Brander, Daniela" uniqKey="Brander D" first="Daniela" last="Brander">Daniela Brander</name>
<name sortKey="Detmar, Michael" sort="Detmar, Michael" uniqKey="Detmar M" first="Michael" last="Detmar">Michael Detmar</name>
<name sortKey="Huggenberger, Reto" sort="Huggenberger, Reto" uniqKey="Huggenberger R" first="Reto" last="Huggenberger">Reto Huggenberger</name>
<name sortKey="Siddiqui, Shoib S" sort="Siddiqui, Shoib S" uniqKey="Siddiqui S" first="Shoib S." last="Siddiqui">Shoib S. Siddiqui</name>
<name sortKey="Ullmann, Stefan" sort="Ullmann, Stefan" uniqKey="Ullmann S" first="Stefan" last="Ullmann">Stefan Ullmann</name>
<name sortKey="Zimmermann, Kathrin" sort="Zimmermann, Kathrin" uniqKey="Zimmermann K" first="Kathrin" last="Zimmermann">Kathrin Zimmermann</name>
</noCountry>
<country name="Suisse">
<noRegion>
<name sortKey="Antsiferova, Maria" sort="Antsiferova, Maria" uniqKey="Antsiferova M" first="Maria" last="Antsiferova">Maria Antsiferova</name>
</noRegion>
<name sortKey="Werner, Sabine" sort="Werner, Sabine" uniqKey="Werner S" first="Sabine" last="Werner">Sabine Werner</name>
</country>
<country name="Finlande">
<region name="Uusimaa">
<name sortKey="Alitalo, Kari" sort="Alitalo, Kari" uniqKey="Alitalo K" first="Kari" last="Alitalo">Kari Alitalo</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005100 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005100 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     PMC:3099581
   |texte=   An important role of lymphatic vessel activation in limiting acute inflammation
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:21364190" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024